BCV
BMY.RT

Banque Cantonale Vaudoise’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,586
Closed -$6K – 1214
2020
Q4 		$6K Hold
10,586
– – ﹤0.01% 1054
2020
Q3 		$24K Buy
10,586
+7,225
+215% +$20.6K ﹤0.01% 966
2020
Q2 		$12K Hold
3,361
– – ﹤0.01% 876
2020
Q1 		$10K Hold
3,361
– – ﹤0.01% 893
2019
Q4 		$8K Buy
+3,361
New +$8.74K ﹤0.01% 885

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Banque Cantonale Vaudoise's BMY.RT Position: Q1 2021 in Review

Banque Cantonale Vaudoise sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,586 shares — an estimated $6K sold.

Banque Cantonale Vaudoise first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $24K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Banque Cantonale Vaudoise reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 10,586 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $6K.
  • Banque Cantonale Vaudoise first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Banque Cantonale Vaudoise's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $24K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2021, filed 11 May 2021.